TMO vs AVGO Stock Comparison: Price, Growth & Valuation (2026)
Use MEXC Stock Compare for a detailed TMO vs AVGO analysis. Compare TMO and AVGO across price performance, growth, valuation, profitability and risk, based on market data and the latest reported financials.
TMO vs AVGO Stock Comparison Summary
TMO reported year-over-year revenue growth of 7.2%, compared with 48.7% for AVGO. Their P/E ratios are 35.3x and 44.3x, dividend yields are 0.27% and 0.00%, and 30-day volatility levels are 24.1% and 36.3%, respectively. These metrics highlight key differences in growth, valuation, dividend income and market risk. Overall TMO leads across more of the selected comparison metrics.
Risk Disclaimer: MEXC Stock Compare provides information and comparisons on actual U.S.-listed stocks for reference only. Data may be delayed or inaccurate, does not constitute investment advice, and past performance does not guarantee future results.
TMO vs AVGO Stock Return Comparison (1W)
Compare the cumulative total returns of Thermo Fisher Scientific, Inc. (TMO) and Broadcom Inc. (AVGO) over the selected 1W period. Data as of 2026-09-24 12:00:00.
TMO vs AVGO Key Equity Metrics Comparison Summary
Thermo Fisher Scientific, Inc. (TMO) has a market capitalization of $244.35B and operates in the Health Care sector, with its main business classified under Life Sciences Tools & Services. Its latest quarterly revenue changed +7.2% year over year.
Broadcom Inc. (AVGO) has a market capitalization of $1.67T and operates in the Information Technology sector, with its main business classified under Semiconductors. Its latest quarterly revenue changed +48.7% year over year.
TMO vs AVGO Key Stock Indicators
| Comparison Metric | TMO | AVGO | Comparison results |
Stock Price & Returns Latest delayed stock price with 1-day, 1-month and year-to-date returns. | $660.851D: +1.3%1M: +6.2%1Y: +40.9% | $349.561D: -1.5%1M: -1.5%1Y: +3.0% | TMOWin |
Market Capitalization Total market value of the company's outstanding shares. | $244.35B | $1.67T | AVGOWin |
Sector & Industry The company's market sector and primary industry classification. | Health Care / Life Sciences Tools & Services | Information Technology / Semiconductors | -- |
| Based on delayed market data, TMO is trading at $660.85, compared with $349.56 for AVGO. Their market capitalizations are $244.35B and $1.67T, respectively. TMO operates in the Health Care sector, while AVGO belongs to Information Technology. | |||
| TMO vs AVGO Growth & Profitability | |||
Revenue Growth (YoY) Year-over-year change in revenue. | +7.2% | +48.7% | AVGOWin |
EPS Growth (YoY) Year-over-year change in earnings per share. | +7.4% | +101.3% | AVGOWin |
ROIC Return generated from invested capital. | 7.8% | 26.0% | AVGOWin |
Gross Margin / Operating Margin Profitability before and after operating expenses. | 40.8% / 17.6% | 68.8% / 48.0% | AVGOWin |
| On growth, TMO posted revenue growth of +7.2% and TTM EPS growth of +7.4%. AVGO, by comparison, posted revenue growth of +48.7% and TTM EPS growth of +101.3%.On profitability, TMO recorded a gross margin of 40.8%, an operating margin of 17.6%, and ROIC of 7.8%. For AVGO, the corresponding figures were 68.8%, 48.0%, and 26.0%.Overall, AVGO shows stronger overall growth and profitability. | |||
| TMO vs AVGO Valuation & Balance Sheet | |||
Free Cash Flow Yield Free cash flow as a percentage of market capitalization. | 3.0% | -- | -- |
Net Debt / EBITDA Net debt relative to EBITDA; a negative value indicates net cash. | 2.6x | 0.9x | AVGOWin |
Dividend Yield / Payout Ratio Dividend returns relative to share price and the share of earnings paid as dividends. | 0.27% / 9.6% | 0.00% / 0.0% | TMOWin |
| The two stocks offer a similar free cash flow yield, indicating comparable valuations. AVGO has the stronger balance sheet, while TMO provides the higher dividend yield. Overall, the two stocks differ mainly in valuation, financial strength and dividend income. | |||
| TMO vs AVGO Returns & Risk | |||
Total Return (Dividend-Adjusted) Cumulative return over 1, 5 and 10 years, including dividends. | 1Y: +40.9%5Y: +8.2%10Y: +322.3% | 1Y: +3.0%5Y: +592.3%10Y: +1,997.0% | AVGOWin |
30-Day Realized Volatility Annualized volatility based on the past 30 days of daily returns. | 24.1% | 36.3% | TMOWin |
Beta (5Y vs S&P 500) Sensitivity to market movements; above 1 indicates greater market volatility. | 0.85 | 1.63 | TMOWin |
| AVGO has delivered stronger long-term returns, but AVGO also shows higher recent volatility and market sensitivity. | |||
TMO vs AVGO Valuation & Dividend Metrics
Review TMO compared with AVGO across valuation, cash flow and dividend metrics, including P/E, forward P/E, free cash flow yield and dividend yield. These figures are provided for reference only and do not represent a fair-value estimate, price target or investment recommendation.
| Metric | TMO | AVGO | Comparison results |
|---|---|---|---|
Market Cap | $244.35B | $1.67T | AVGOWin |
P/E (TTM) | 35.3x | 44.3x | TMOWin |
P/S | 5.3x | 19.0x | TMOWin |
EV/EBITDA | 25.0x | 33.3x | TMOWin |
Dividend Yield | 0.27% | 0.00% | TMOWin |
TMO vs AVGO Profitability Over Time
Compare TMO and AVGO across gross margin and operating margin trends over time to understand how each company's profitability has changed. Based on reported financial data only; not a forecast or investment advice.
| TTM | 3Y Avg | 5Y Avg | 10Y Avg | |
|---|---|---|---|---|
| TMO | 40.9% | 40.7% | 42.9% | 44.4% |
| AVGO | 67.8% | 66.6% | 65.5% | 61.4% |
Technical & Fundamental Stock Analysis
RSI (14, daily)
TMO 67.76 • AVGO 41.50
Measures short-term price momentum and helps identify possible overbought or oversold conditions.
50/200-DMA Position
TMO 50D Above / 200D Above • AVGO 50D Below / 200D Below
Shows whether the stock is trading above or below its medium- and long-term trend lines.
R&D % of Revenue
TMO 3.0% • AVGO 13.3%
Shows how much of revenue is invested in research and development.
Share Count Trend (3Y)
TMO Decreased • AVGO Increased
Shows whether the company's share count has increased or decreased over the past three years.
Company Profiles
Thermo Fisher Scientific, Inc.
Life Sciences Tools & Services
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Broadcom Inc.
Semiconductors
Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.
Trade TMO & AVGO Stock Futures on MEXC
Trade USDT-margined Stock Futures referencing TMO and AVGO on MEXC, with 24/7 access and leverage of up to 10x. These products are derivatives, do not represent ownership of the underlying shares and involve a significant risk of loss.
Everything You Need to Know About TMO vs AVGO Stocks
What is MEXC Stock Compare?
MEXC Stock Compare is a side-by-side US stock comparison tool. It helps users compare two companies across stock price performance, market cap, valuation, growth, profitability, balance-sheet strength, dividends and risk. The results are provided for research purposes only and do not constitute investment advice.
Which metrics should I use to evaluate a company's growth?
Start with revenue growth to see how quickly the business is expanding, then review EPS growth to determine whether that growth is translating into higher earnings per share. Gross margin, operating margin and ROIC help assess the quality of that growth by showing profitability and capital efficiency. A company with fast revenue growth but declining margins may be expanding without improving its earnings quality.
How do TMO and AVGO compare in growth and profitability?
In the latest reported period, TMO recorded revenue growth of +7.2% and TTM EPS growth of +7.4%, compared with +48.7% and +101.3% for AVGO. AVGO leads on both growth and profitability. This comparison is based on reported financial metrics and does not predict future performance.
What is the difference between P/E (TTM) and Forward P/E?
P/E (TTM) compares the current share price with actual earnings reported over the past 12 months. Forward P/E uses estimated earnings for the next 12 months, so it reflects market expectations but depends on forecasts that may change. Both ratios should be considered alongside growth, profitability and industry peers.
How do the risk profiles of TMO and AVGO compare?
TMO has a 30-day realized volatility of 24.1% and a five-year Beta of 0.85, compared with 36.3% and 1.63 for AVGO. AVGO shows higher historical volatility and market sensitivity. These indicators describe historical price movements and market sensitivity, but they do not cover every source of investment risk.
What do dividend yield and payout ratio indicate?
Dividend yield shows the annual dividend relative to the current share price, while the payout ratio shows how much of a company's earnings is distributed as dividends. A higher yield may provide more income, but it can also rise because the share price has fallen. Dividend sustainability should therefore be considered together with earnings, cash flow and the payout ratio.
How should I compare a high-growth stock with a lower-valued stock?
A high-growth stock may trade at a higher valuation if investors expect its revenue and earnings to continue expanding. A lower-valued stock may offer a more conservative entry point, but the lower valuation could also reflect slower growth or higher business risk. Growth, valuation, profitability, cash flow and risk should therefore be considered together.
Which is the better stock, TMO or AVGO?
There is no single answer for every investor. Growth-focused investors may place greater weight on revenue growth, EPS growth and ROIC, while income-focused investors may prioritize dividend yield and payout sustainability. Investors with lower risk tolerance may focus more on volatility, Beta and balance-sheet strength. MEXC Stock Compare presents the relevant metrics but does not provide a buy or sell recommendation.
Can I trade TMO and AVGO as RealStocks on MEXC?
Eligible users can trade TMO and AVGO as real US stocks through MEXC RealStocks if both stocks are currently supported. Users must first open and verify a RealStocks account with MEXC's partner licensed broker. RealStocks represents ownership of actual shares rather than tokenized stock exposure. Availability may vary by stock and region, so users should check the corresponding RealStocks trading page before placing an order.
Disclaimer
The stock prices, financial metrics, comparison results and related information displayed on this page are sourced from third-party providers and are provided for informational and educational purposes only. Data may be delayed, incomplete or inaccurate, and MEXC does not guarantee its accuracy, completeness or timeliness. The comparisons and automated summaries do not constitute financial, investment, legal or tax advice, nor a recommendation to buy, sell or hold any security or financial product. Past performance is not indicative of future results. Users should independently verify the information and assess their own objectives, financial circumstances and risk tolerance before making any decision. Where MEXC stock futures or other derivative products are referenced, such products do not represent ownership of the underlying shares and may involve leverage and a substantial risk of loss. Product availability is subject to applicable laws and regional restrictions.